Image-1 (33a5de83 A974 48a5 8ba6 4c1b97515615 01)
Tramadol Hydrochloride Tablet, Extended Release
Product Images NDC 68071-5078
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 68071-5078). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image-2 (33a5de83 A974 48a5 8ba6 4c1b97515615 02)
The text represents a graph showing the concentration (in ng/mL) of Tramadol over time (in hours) for two types of medications: Tramadol Hydrochloride Extended-Release Tablets (at a dose of 200 mg per day) and Tramadol Hydrochloride Tablets (at a dose of 50 mg every 6 hours).*
Image-3 (33a5de83 A974 48a5 8ba6 4c1b97515615 03)
This is a chart that demonstrates the concentration of M1 over time using Tramadol Hydrochloride Extended-Release Tablets and Tramadol Hydrochloride Tablets. The concentration is measured in ng/mL, and the time is measured in hours. So, it is a comparison between two forms of Tramadol Hydrochloride Tablets.*
Image-4 (33a5de83 A974 48a5 8ba6 4c1b97515615 04)
This appears to be a graph that displays the percentage of patients who achieved varying levels of response threshold for pain relief while taking different doses of Tramadol Hydrochloride Extended-Release Tablets. The graph also shows the percentage of patients who achieved response while taking a placebo. The data is presented as a study called "023 WOMAC Pain Responder Analysis".*
Image-5 (33a5de83 A974 48a5 8ba6 4c1b97515615 05)
This is a table showing the effectiveness of Tramadol Hydrochloride Extended-Release Tablets in treating Arthritis Pain. The table presents the percentage of patients who achieved various levels of response threshold using the Visual Analog Scale (VAS) Responder Analysis. The response threshold denotes the percent improvement from the baseline, and the graph compares the percentage of patients who reached the response threshold between the group that received Tramadol Hydrochloride Extended-Release Tablets and the Placebo group.*
Pdp (68071 5078 3)
This is a label description of Tramadol HCI 300mg E-R Tablets manufactured by NuCare Pharmaceuticals, Inc. The label shows the product name, NDC and GTIN codes, ingredients, and a warning to keep the medicine out of reach of children and store at controlled temperature. The product is only available with a prescription. Contact a healthcare professional for advice. The product has a serial number, manufacturer's label, and expiration date. LOT # is 000000.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
